Psychedelic Therapy

FDA Endorses CaaMTech's Psilocin Drug Development For Depression Treatment

Psychoanalysis Meets LSD: Argentina's Lost 1950s Era Of Psychedelic Therapy

Elon Musk On Ketamine And Investors' Value: 'If There Is Something I'm Taking, I Should Keep Taking It'

Psychoanalysis Meets LSD: Argentina's Lost 1950s Era Of Psychedelic Therapy

Elon Musk On Ketamine And Investors' Value: 'If There Is Something I'm Taking, I Should Keep Taking It'

Denver To Become First US City To Train First Responders In Psychedelics Crisis Intervention

Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More

Denver To Become First US City To Train First Responders In Psychedelics Crisis Intervention

Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More

Which Are The Strongest Psychedelics Out There? Brief Overview, Rankings And Practical Insights

More Protocols And Guidance Are Needed As Momentum Builds For Veterans, Psychedelics, And Mental Health

Psychedelic Therapy Recent News

Numinus Reports Q4 & Full Year Fiscal 2023 Results, Including Greatly Reduced Cash Burn Rate

Psychedelic therapy clinic provider Numinus Wellness (TSX:NUMI) (OTC: NUMIF) announced

Psychiatrists Increasingly Open To Psychedelic Therapies, Study Confirms

This article was originally published on Psychedelic Spotlight and appears here with permission. Psychiatrists in the United States are increasingly warming up to the idea of treating patients with psychedelics.

Revolutionizing Psychiatry: More Than 80% Of Psychiatrists See Promise In Psychedelics Or Hallucinogens

This article was originally published on Psychedelic Spotlight and appears here with permission. Psychiatrists in the United States are increasingly warming up to the idea of treating patients with psychedelics.

Can Psychedelic Therapy Enhance Quality Of Life In Seniors?

This article was originally published on Microdose and appears here with permission.

Psychedelic Journeys 2.0: How Virtual Reality Is Revolutionizing Therapy

This article was originally published on Microdose and appears here with permission.

Cybin's Q1 2023 Financials, Deuterated Psychedelics Moving 'Steadily' Through The Clinic

Canadian clinical-stage psychedelics company Cybin (NYSE: CYBN) shared its unaudited financial results for the first quarter ended June 30, 2023:

How Does Race And Ethnicity Influence Psychedelic Mental Health Outcomes?

This article was originally published on Psychedelic Spotlight and appears here with permission. Psychedelic therapy is growing in popularity, but clinical trials often overlooks the unique needs of diverse racial and ethnic populations

Psychedelic Treatments Vary Greatly By Cost And Setting, What About Efficacy?

Psychedelic therapy is on the rise. June 2022 data from Data Bridge Market Research reports that the US psychedelic drug market could be valued at $9.8 billion by 2029, with a nearly 17% CAGR.

A Brief History Of MDMA: From The CIA To Raves To Psychedelic Therapy

This article was originally published on Psychedelic Spotlight and appears here with permission. Today, MDMA is one of the world’s most-well known drugs. Famous as a party drug prevalent among concertgoers, the compound is also growing in popularity as a therapy-enhancing medicine.

Promising Psychedelic Therapy Legislation Set To Make Waves In 2022

This article was originally published on Psychedelic Spotlight and appears here with permission.

Ei.Ventures To Host Psychedelic Therapies In Metaverse, Saying It's "The Only Way To Scale"

Miami-based psychedelics startup Ei.Ventures announced this week that it has purchased a virtual land estate in The Sandbox, where clinicians will be able to host psychedelic therapy sessions in the metaverse,